Seeing Is Believing
STRO is currently covered by 4 analysts with an average potential upside of $9.65 (137.18%) backed by displayed 10 price targets and 18 ratings.
Analysts average stock forecasts to be materialized ratio is 31.55% with an average time for these price targets to be met of 151.86 days.
Highest price target for STRO is 11, Lowest price target is 2, average price target is 6.5.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 15-Nov-2023. First documented stock forecast 29-Apr-2019.
Currently, out of the existing stock ratings of STRO - 11 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
12
$9.69 (419.48%)
15 days ago
1/4 (25%)
$8.26 (128.34%)
28
Buy
12
$9.69 (419.48%)
1 months 7 days ago
0/1 (0%)
$9.05 (306.78%)
Buy
2 months 24 days ago
2/3 (66.67%)
$7.35 (40.59%)
172
Buy
17
$13.81 (432.92%)
17
3 months 16 days ago
1/8 (12.5%)
$10.04 (175.42%)
24
Buy
16
$12.81 (401.57%)
16
3 months 19 days ago
1/6 (16.67%)
$11.51 (171.26%)
568
What is STRO (Sutro Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?
Which analyst has the current lower performing score on STRO (Sutro Biopharma) with a proven track record?
Which analyst has the most public recommendations on STRO (Sutro Biopharma)?
Which analyst is the currently most bullish on STRO (Sutro Biopharma)?
Which analyst is the currently most reserved on STRO (Sutro Biopharma)?